Strategic Partners
Platinum
Boston Scientific’s mission is to transform lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is dedicated to collaborating with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, increase efficiencies and—most importantly—help more people in more places around the world live longer, healthier lives.
Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co is one of Israel’s leading law firms and is widely recognized for its local and global transactional experience. GKH is a “one-stop shop”, providing a full range of legal services. GKH has over 30 years of experience representing countless life sciences companies, ranging from seed stage start-ups to well-established global companies, and has acquired in-depth knowledge of Israel’s life sciences market and its legal requirements. GHK is ranked top-tier by The Legal 500 in the practice of Healthcare & Life Sciences.
Gold
BioStats Statistical Consulting LTD, a leading boutique biostatistics consulting firm has been fulfilling the needs of the biomedical industry for over 15 years. Combining deep knowledge of bio-statistics with unparalleled industry expertise, we are responsible for a rich list of successful regulatory submissions (US, Europe, Asia) of medical devices and biologics.
Via our core biostatistics and data management business, our highly experienced bio-statisticians, who are committed to providing excellent service, will add value as they accompany you through the entire process from the pre-clinical stage through regulatory submission.
CellCure Neurosciences Ltd. is a biotechnology company owned by BioTime, Teva Pharmaceutical Industries and Hadasit Bio-Holdings is focused on developing cell based therapies for retinal and neural degenerative disease. Our first developed product, OpRegen®, is aimed to treat Age-Related Macular Degeneration, based on human embryonic stem cells (hESC), which, for the first time in the history of medicine, open the door to industrial-scale manufacture of any cell type in the human body.
Ephraim Abramson Law Offices is one of the leading law firms in Israel with a dynamic and diversified practice, which encompasses nearly all areas of domestic and international commercial representation. Ephraim Abramson & Co. has significant experience with complex transactional work of substantial scope, both in Israel and abroad, and the full range of day-to-day representation of its clients in a wide range of industries including start-up and mature private and publicly-traded corporations, venture capitalists, individual entrepreneurs, major non-profit and government-related institutions, and Israeli government ministries and agencies.
Luneau Technology / Visionix®, Briot®, Weco® is a global developer and supplier of ophthalmic equipment, extending from refraction and diagnostic tools to equipment for labs and finishing. Luneau Technology features diagnostic devices, specialized optotypes, displays, and ophthalmic technologies enhanced by the expertise of Visionix®, Briot®, and Weco®, a long time edger developer and manufacturer, is renowned for innovation and expertise in finishing.
Boosted by Luneau Technology, the three brands, Visionix®, Briot® and Weco®, have combined synergies and have multiplied their portfolio, allowing Luneau Technology to provide solutions for the daily requirements of Eye Care Professionals : opticians, ophthalmic professionals, and practitioners.
Silver
Ato*Bio is a late stage biotechnology company that develops novel immunomodulators for critically ill patients. Reltecimod, Ato*Bio’s lead product, is initially being developed to treat Necrotizing Soft Tissue Infections (NSTI), a rare, life threatening infection with high morbidity and mortality. Reltecimod is currently being studied in ACCUTE (Reltecimod Clinical Composite endpoint StUdy in necrotizing soft Tissue InfEctions) , a phase 3 clinical trial evaluating its efficacy in patient with NSTI. Previously, Reltecimod completed a phase 2 study in NSTI. Results demonstrated that patients treated with Reltecimod had a meaningful improvement across multiple end points.
Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. We transform the cutting-edge research coming out of Hadassah into marketable medical technologies. We turn ground-breaking ideas into viable products and services that can change the world and better humanity.
More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and we are dedicated to bringing these life-saving technologies to the general public.
HIL Applied Medical is developing a new class of ultra-compact, high-performance cancer Proton Therapy systems, which combines nanotechnology, high-intensity lasers and ultra-fast magnets – paving the way for truly cost-effective, expandable, add-on, single-room solutions.
Imagine Bio supports healthcare and pharma leaders strengthen their innovation strategy while leveraging the unique strengths of Israel’s digital health and life science ecosystem. Our startup practice develops effective business strategies and focused messaging to successfully attract strategic partners and investment. We operate globally with clients based in the US, Europe, and Asia.
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require for accurate personalized therapy based on comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive tumor’s progression.
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies. Its flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics around the world – allowing type 2 patients to begin insulin therapy without fear of needles. Oramed’s oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes.
Pepticom Ltd. was founded in 2011 to revolutionize the discovery of novel peptide drug candidates using its key asset, an exceptional artificial intelligence platform aimed at designing peptide ligands based upon solved crystal structures which enables Pepticom to operates in various disciplines and generate innovative binding peptides for diverse targets.
POMICELL’s mission is to accelerate drug discovery and development. Using an automatic, AI-based platform that supports biotech and Pharma companies’ decision-making processes. POMICELL expedites and optimizes the researchers’ most crucial R&D decisions.
POMICELL’s unique approach offers an unprecedented combination of technology, methodology, metadata, and expertise. With access to large-scale external databases, we augment the data millions-fold, automate and tailor adjust the platform to specific R&D needs, and answer the most painful questions biotech and pharma companies ask.
RenalSense is a medical device company dedicated to real-time renal diagnostics. Its flagship product, Clarity RMS, changes the practice of ICU and critical care management by providing continuous, automatic monitoring of urine flow. This facilitates early detection of changes in renal function and the risk of Acute Kidney Injury (AKI) – enabling rapid intervention, better patient care, and improved ICU economics.
Semorex develops and commercializes innovative and novel targeted therapeutics utilizing our Selective Molecular Recognition technology for cancer patients.
TenCure is set to transform the field of Oncology therapeutics by developing a new class of targeted personalized treatments for skin, pancreatic and colon cancer, based on inhibition of Diabetes induced genes.
Terralab Ventures is dedicated to finding and growing the technologies and innovation that will make tomorrow that much brighter. We believe in the power of entrepreneurship, technology and operational excellence. We harness this power each day by investing in and growing game changing ventures that have the potential to influence millions of lives and positively impact the world.
Our team works closely with entrepreneurs to jumpstart ideas and achieve business objectives. We aren’t just there to finance, we want to get our hands dirty with you and really make things happen.
Tetrax FB poses an innovative, highly effective diagnostic System for the detection of subtle Neuro-Physiological disorders and Neuro-Anatomic Disturbances based on human posture analysis.
Valera Health was founded on the belief that effective behavioral health management is key to overall wellbeing. We are passionate about creating personalized and preventive behavioral health solutions that are scalable, innovative, and effective. We ground our solutions in evidence-based models and innovate with cutting-edge digital technology and data analytics. Our team draws from decades of experience implementing integrated care in clinical practice, and working in behavioral health, data analytics, healthcare policy, pharmaceuticals, venture capital, startups and academia.
